Lifeway Foods Earnings Call Transcripts
Fiscal Year 2026
-
Record first quarter with $63M net sales (up 36.7% YoY), gross margin up 360 bps, and net income up 32%. Growth driven by flagship products, innovation, and strong consumer trends in health and nutrition.
Fiscal Year 2025
-
Record net sales and net income growth were driven by strong demand for core products, expanded distribution, and new product launches. Gross margin and profitability improved, with continued investment in capacity and innovation supporting a positive outlook for 2026.
-
Record Q3 net sales rose 24% year-over-year, driven by strong demand for kefir and Farmer Cheese, with gross margin up 300 basis points. Facility expansion and new product launches support continued growth, and adjusted EBITDA is targeted at $45–$50 million by 2027.
-
Record Q2 2025 net sales of $53.9M and 18% volume-led growth extended a 23-quarter streak. Gross margin rose to 28.6%, net income reached $4.2M, and early Q3 sales show continued acceleration. Capital investments are boosting capacity and distribution.
-
Record net sales and double-digit growth in 2024 were driven by strong demand for drinkable kefir and new product innovations. Gross margin held at 26%, with net income of $9 million, and expanded distribution for Farmer Cheese and ProBugs.
Fiscal Year 2024
-
Q3 2024 saw 12.7% net sales growth, marking 20 consecutive quarters of expansion, with strong volume gains in Drinkable Kefir and new product launches. Gross margin improved, capital spending rose to support growth, and international expansion advanced.
-
Record Q2 net sales grew 25.3% year-over-year to $49.2 million, with gross margin and net income also improving. Strong volume growth in kefir and new product innovations drive momentum, positioning the company for another record year.